VEGFA and lung adenocarcinoma: Treatment with bLF was able to reduce the proliferation of a human lung adenocarcinoma cell line (A549) by decreasing the expression of the VEGF protein and oral bLF in transgenic mice overexpressing VEGF and developing lung tumors suppressed inflammation, eliminated the expression of hVEGF-A165 and reduced solid tumor formation [197].